1/24
06:28 pm
ubx
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan [TechCrunch]
Low
Report
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan [TechCrunch]
1/10
08:49 am
ubx
Unity Biotechnology, Inc. (NASDAQ: UBX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $6.00 price target on the stock.
High
Report
Unity Biotechnology, Inc. (NASDAQ: UBX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $6.00 price target on the stock.
1/7
04:10 pm
ubx
UNITY Biotechnology Reports Granting of New Employment Inducement Award
High
Report
UNITY Biotechnology Reports Granting of New Employment Inducement Award
1/6
08:00 am
ubx
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
High
Report
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
11/19
08:04 am
ubx
Industry Veterans Announce Jupiter Bioventures, a Biotechnology Venture Foundry that Turns Novel Science into Transformational Companies [Yahoo! Finance]
Medium
Report
Industry Veterans Announce Jupiter Bioventures, a Biotechnology Venture Foundry that Turns Novel Science into Transformational Companies [Yahoo! Finance]
11/4
04:45 pm
ubx
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]
Medium
Report
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]
11/4
04:30 pm
ubx
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
Medium
Report
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates